Chicago, IL, United States of America

Liufu Deng


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal1 out of 832,718 
Other
 patents

Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Liufu Deng

Introduction

Liufu Deng is a notable inventor based in Chicago, IL, who has made significant strides in the field of cancer treatment. His work focuses on developing therapies that enhance the effectiveness of existing cancer treatments. With a single patent to his name, Deng's contributions are both innovative and impactful.

Latest Patents

Liufu Deng holds a patent for an anti-tumor therapy. This patent discloses compositions, kits, and methods for treating cancer in subjects in need thereof. The invention involves one or more genes whose suppression renders the cancer chemosensitive and/or radiosensitive. This advancement has the potential to improve treatment outcomes for cancer patients.

Career Highlights

Throughout his career, Liufu Deng has demonstrated a commitment to advancing medical science. His research has focused on the intersection of genetics and cancer therapy, leading to innovative solutions that address critical challenges in treatment efficacy. His work is a testament to the importance of research and development in the medical field.

Collaborations

Liufu Deng has collaborated with esteemed colleagues such as Yang-xin Fu and Nikolai Khodarev. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research and innovation in cancer treatment.

Conclusion

Liufu Deng's contributions to cancer therapy exemplify the vital role of inventors in advancing medical science. His innovative approach to enhancing treatment efficacy through genetic research is a significant step forward in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…